Insider Transactions in Q1 2021 at Cto Realty Growth, Inc. (CTO)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 17
2021
|
Lisa Vorakoun VP & CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,500
-30.46%
|
$84,000
$56.1 P/Share
|
Mar 15
2021
|
Daniel Earl Smith SVP, GEN COUNSEL & CORP SECRET |
BUY
Exercise of conversion of derivative security
|
Direct |
3,541
+10.73%
|
$138,099
$39.87 P/Share
|
Mar 11
2021
|
John P Albright PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,330
-4.52%
|
$746,480
$56.1 P/Share
|
Mar 11
2021
|
John P Albright PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,083
+4.84%
|
$678,735
$45.1 P/Share
|
Mar 04
2021
|
John P Albright PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,476
-8.85%
|
$741,180
$55.07 P/Share
|
Mar 04
2021
|
John P Albright PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.97%
|
$675,000
$45.85 P/Share
|
Mar 03
2021
|
John P Albright PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,894
-6.09%
|
$480,276
$54.24 P/Share
|
Mar 03
2021
|
John P Albright PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.41%
|
$440,000
$44.35 P/Share
|
Feb 26
2021
|
Lisa Vorakoun VP & CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
861
-14.88%
|
$44,772
$52.05 P/Share
|
Feb 10
2021
|
Lisa Vorakoun VP & CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
1,915
+24.87%
|
-
|
Feb 10
2021
|
Laura M Franklin |
BUY
Grant, award, or other acquisition
|
Direct |
788
+9.59%
|
$34,672
$44.38 P/Share
|
Feb 10
2021
|
Howard C Serkin |
BUY
Grant, award, or other acquisition
|
Direct |
788
+6.03%
|
$34,672
$44.38 P/Share
|
Feb 10
2021
|
George R Brokaw |
BUY
Grant, award, or other acquisition
|
Direct |
788
+6.14%
|
$34,672
$44.38 P/Share
|
Feb 10
2021
|
Casey R Wold |
BUY
Grant, award, or other acquisition
|
Direct |
788
+9.73%
|
$34,672
$44.38 P/Share
|
Feb 10
2021
|
Christopher W Haga |
BUY
Grant, award, or other acquisition
|
Direct |
788
+10.77%
|
$34,672
$44.38 P/Share
|
Feb 10
2021
|
Robert Blakeslee Gable |
BUY
Grant, award, or other acquisition
|
Direct |
788
+11.71%
|
$34,672
$44.38 P/Share
|
Feb 10
2021
|
Matthew Morris Partridge SR. VP, CFO & TREASURER |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+28.41%
|
-
|
Feb 10
2021
|
John P Albright PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,803
+6.72%
|
-
|
Feb 10
2021
|
Steven Robert Greathouse SVP & CHIEF INVESTMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,101
+15.49%
|
-
|
Feb 10
2021
|
Daniel Earl Smith SVP, GEN COUNSEL & CORP SECRET |
BUY
Grant, award, or other acquisition
|
Direct |
2,900
+10.06%
|
-
|
Feb 09
2021
|
John P Albright PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,222
-1.73%
|
$99,990
$45.68 P/Share
|
Feb 09
2021
|
John P Albright PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,128
+6.63%
|
-
|
Feb 09
2021
|
Steven Robert Greathouse SVP & CHIEF INVESTMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
484
-2.58%
|
$21,780
$45.68 P/Share
|
Feb 09
2021
|
Steven Robert Greathouse SVP & CHIEF INVESTMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,029
+9.76%
|
-
|
Feb 09
2021
|
Daniel Earl Smith SVP, GEN COUNSEL & CORP SECRET |
SELL
Payment of exercise price or tax liability
|
Direct |
490
-2.08%
|
$22,050
$45.68 P/Share
|
Feb 09
2021
|
Daniel Earl Smith SVP, GEN COUNSEL & CORP SECRET |
BUY
Grant, award, or other acquisition
|
Direct |
2,020
+7.91%
|
-
|
Jan 28
2021
|
Lisa Vorakoun VP & CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
422
-9.83%
|
$18,146
$43.01 P/Share
|
Jan 28
2021
|
John P Albright PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,155
-1.77%
|
$92,665
$43.01 P/Share
|
Jan 28
2021
|
John P Albright PRESIDENT & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,000
-15.32%
|
-
|
Jan 28
2021
|
Daniel Earl Smith SVP, GEN COUNSEL & CORP SECRET |
SELL
Payment of exercise price or tax liability
|
Direct |
719
-3.24%
|
$30,917
$43.01 P/Share
|
Jan 28
2021
|
Steven Robert Greathouse SVP & CHIEF INVESTMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
806
-4.6%
|
$34,658
$43.01 P/Share
|
Jan 04
2021
|
Casey R Wold |
BUY
Grant, award, or other acquisition
|
Direct |
341
+4.97%
|
$13,640
$40.96 P/Share
|
Jan 04
2021
|
George R Brokaw |
BUY
Grant, award, or other acquisition
|
Direct |
366
+3.15%
|
$14,640
$40.96 P/Share
|
Jan 04
2021
|
Laura M Franklin |
BUY
Grant, award, or other acquisition
|
Direct |
317
+4.54%
|
$12,680
$40.96 P/Share
|
Jan 04
2021
|
Robert Blakeslee Gable |
BUY
Grant, award, or other acquisition
|
Direct |
317
+5.8%
|
$12,680
$40.96 P/Share
|
Jan 04
2021
|
Christopher W Haga |
BUY
Grant, award, or other acquisition
|
Direct |
390
+6.36%
|
$15,600
$40.96 P/Share
|
Jan 04
2021
|
Howard C Serkin |
BUY
Grant, award, or other acquisition
|
Direct |
329
+2.78%
|
$13,160
$40.96 P/Share
|